312 related articles for article (PubMed ID: 24201999)
1. Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies.
Do AL; Wong CR; Nguyen LH; Nguyen VG; Trinh H; Nguyen MH
J Clin Gastroenterol; 2014 Aug; 48(7):644-9. PubMed ID: 24201999
[TBL] [Abstract][Full Text] [Related]
2. High Prevalence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Thailand.
Wanich N; Vilaichone RK; Chotivitayatarakorn P; Siramolpiwat S
Asian Pac J Cancer Prev; 2016; 17(6):2857-60. PubMed ID: 27356702
[TBL] [Abstract][Full Text] [Related]
3. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.
Singal AK; Salameh H; Kuo YF; Fontana RJ
Aliment Pharmacol Ther; 2013 Jul; 38(2):98-106. PubMed ID: 23713520
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems.
Wong RJ; Jain MK; Therapondos G; Niu B; Kshirsagar O; Thamer M
Am J Gastroenterol; 2021 Jul; 116(7):1465-1475. PubMed ID: 33661148
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
[TBL] [Abstract][Full Text] [Related]
7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
8. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY
J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933
[TBL] [Abstract][Full Text] [Related]
9. Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients.
Liu M; Tseng TC; Jun DW; Yeh ML; Trinh H; Wong GLH; Chen CH; Peng CY; Kim SE; Oh H; Kwak MS; Cheung M; Toyoda H; Hsu YC; Jeong JY; Yoon EL; Ungtrakul T; Zhang J; Xie Q; Ahn SB; Enomoto M; Shim JJ; Cunningham C; Jeong SW; Cho YK; Ogawa E; Huang R; Lee DH; Takahashi H; Tsai PC; Huang CF; Dai CY; Tseng CH; Yasuda S; Kozuka R; Li J; Wong C; Wong CC; Zhao C; Hoang J; Eguchi Y; Wu C; Tanaka Y; Gane E; Tanwandee T; Cheung R; Yuen MF; Lee HS; Yu ML; Kao JH; Yang HI; Nguyen MH
Hepatol Int; 2021 Feb; 15(1):71-81. PubMed ID: 33394321
[TBL] [Abstract][Full Text] [Related]
10. Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
Ahn J; Lim JK; Lee HM; Lok AS; Nguyen M; Pan CQ; Mannalithara A; Te H; Reddy KR; Trinh H; Chu D; Tran T; Lau D; Leduc TS; Min A; Trong Le L; Bae H; Van Tran S; Do S; Hann HW; Wong C; Han S; Pillai A; Park JS; Tong M; Scaglione S; Woog J; Kim WR
Am J Gastroenterol; 2016 Sep; 111(9):1297-304. PubMed ID: 27325221
[TBL] [Abstract][Full Text] [Related]
11. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
[TBL] [Abstract][Full Text] [Related]
12. Kentucky hepatoma: epidemiologic variant or same problem in a different region?
Martin RC; Loehle J; Scoggins CR; McMasters KM
Arch Surg; 2007 May; 142(5):431-6; discussion 436-7. PubMed ID: 17515484
[TBL] [Abstract][Full Text] [Related]
13. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
Chalasani N; Said A; Ness R; Hoen H; Lumeng L
Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
[TBL] [Abstract][Full Text] [Related]
14. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
Ann Surg Oncol; 2014 Feb; 21(2):458-65. PubMed ID: 24132624
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
16. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups.
Mancebo A; González-Diéguez ML; Cadahía V; Varela M; Pérez R; Navascués CA; Sotorríos NG; Martínez M; Rodrigo L; Rodríguez M
Clin Gastroenterol Hepatol; 2013 Jan; 11(1):95-101. PubMed ID: 22982095
[TBL] [Abstract][Full Text] [Related]
17. Histological characteristics predisposing to development of hepatocellular carcinoma in patients with chronic hepatitis B.
Lee SH; Chung YH; Kim JA; Jin YJ; Park WH; Choi JG; Lee D; Shim JH; Yu E; Jang MK
J Clin Pathol; 2011 Jul; 64(7):599-604. PubMed ID: 21572113
[TBL] [Abstract][Full Text] [Related]
18. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
[TBL] [Abstract][Full Text] [Related]
19. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of interferon therapy on incidence of cirrhosis and hepatocellular carcinoma in Thai patients with chronic hepatitis B.
Tangkijvanich P; Thong-ngam D; Mahachai V; Kladchareon N; Suwangool P; Kullavanijaya P
Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):452-8. PubMed ID: 11944697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]